BlackRock
TTRX

BlackRock’s Turn Therapeutics TTRX Stock Holding History

BlackRock’s Portfolio TTRX Stock Details TTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Buy
+38,591
New +$179K ﹤0.01% 4720

Other funds holding TTRX

SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
DI
DDFG Inc Thousand Oaks, California $504M AUM 18.61% 1-Year Est. Return
BA
Bridgewater Advisors New York $1.83B AUM 22.9% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
TS
Tamar Securities Woodland Hills, California $1.07B AUM 26.86% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
MMA
Miracle Mile Advisors Los Angeles, California $8.53B AUM 21.43% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
CFS
Cannon Financial Strategists Athens, Georgia $879M AUM 22.04% 1-Year Est. Return

BlackRock's TTRX Position: Q2 2026 in Review

BlackRock opened a new position in Turn Therapeutics (TTRX) in Q2 2026: 38,591 shares worth $282K. The stake represents ﹤0.01% of the portfolio and ranks #4720 among its holdings.

14 funds tracked by Wall St. Rank hold TTRX as of Q2 2026.

  • BlackRock held 38,591 shares of Turn Therapeutics worth $282K as of Q2 2026.
  • Turn Therapeutics was a new BlackRock position in Q2 2026.
  • Turn Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4720 holding.
  • 14 funds tracked by Wall St. Rank held Turn Therapeutics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.